On October 1, 2025, Qualigen Therapeutics, Inc. announced that WithumSmith+Brown, PC resigned as its independent auditor, effective immediately; they appointed Macias Gini & O’Connell LLP as the new auditor starting October 3, 2025. Additionally, Jiawei Wang and Koti Meka were appointed as Co-CEOs and CFO, respectively, on October 2, 2025, following the resignation of three board members, with the changes linked to a private placement that occurred on September 29, 2025.